Delivery Order SPE2DB24D2109-SPE2DB25FHWFV

Award Date 1/17/25
Potential Completion Date 1/21/25
Potential Value $104K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, SPE2DB22D2009|SPE2DB25FL7VQ, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,862.33 Firm Fixed Price delivery order contract is for the supply of JARDIANCE 25 MG TABLET 90S, a pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,766.63 firm fixed-price delivery order is for the supply of JARDIANCE 25 MG TABLET 90S, a pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical division. This IDC serves as a primary vehicle...
This federal contract award, SPE2DB20D1110|SPE2DB24FJ91Z, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $12,411.97 Firm Fixed Price Delivery Order contract is for the supply of JARDIANCE 25 MG TABLET 90S, a pharmaceutical product, with a completion date of February 2, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award, with ID SPE2DB20D2002|SPE2DB25FL29L, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,177.65 firm fixed-price delivery order is for the supply of JARDIANCE 25 MG TABLET 90S, with a performance period through March 24, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award, with ID SPE2DB24D1205|SPE2DB25FCTBL, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,161.68 firm fixed-price delivery order is for the supply of JARDIANCE 10 MG TABLET 90S, a pharmaceutical product, with a completion date of January 16, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,533.02 firm fixed-price delivery order is for the supply of JARDIANCE 10 MG TABLET 90S, a pharmaceutical product, with a completion date of June 4, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,944.14 delivery order contract is for the supply of JARDIANCE 25 MG TABLET 90S, a pharmaceutical product, with a period of performance through March 3, 2025. The award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award, with ID SPE2DB25D3017|SPE2DB25FVGQV, was granted by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,767.61, is for the delivery of JARDIANCE 25 MG TABLET 90S, a pharmaceutical product. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award, with ID SPE2DB22D1017|SPE2DB25FF9EB, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,787.22 firm fixed-price delivery order is for the supply of JARDIANCE 25 MG TABLET 90S, a pharmaceutical product, with an ultimate completion date of April 3, 2025. The award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $32,726.93 firm fixed-price delivery order contract is for the supply of JARDIANCE 25 MG TABLET 90S, a medical product. The contract has an ultimate completion date of January 3, 2025. This award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
  • SPE2DB24D2109
    Indefinite Delivery Contract
  • SPE2DB24D2109-SPE2DB25FHWFV
    Delivery Order

This federal contract award, with ID SPE2DB24D2109|SPE2DB25FHWFV, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $104,430.15 firm fixed-price delivery order contract covers the supply of the pharmaceutical product JARDIANCE 25 MG TABLET 90S.

This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has no set-aside designation, indicating open competition.

Generated 5/21/25, 10:03 AM